References
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-988.
Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (The Cardiovascular Health Study). Am J Cardiol 1994;74:236-241.
Lake FR, Cullen KJ, de Klerk NH, McCall MG, Rosman DL. Atrial fibrillation and mortality in an elderly population. Aust NZ J Med 1989;19:321-326.
Phillips SJ, Whisnant JP, O'Fallon WM, Frye RL. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 1990;65:344-359.
Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation; Analysis and implications. Arch Intern Med 1995;155:469-473.
Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997;96:2455-2461.
Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271:840-844.
Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D'Agostino RB. Secular trends in the prevalence of atrial fibrillation, The Framingham Study. Am Heart J 1996;131:790-795.
Stafford RS, Singer DE. National patterns of warfarin use in atrial fibrillation. Arch Intern Med 1996;156:2537-2541.
Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D'Agostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994;331:1249-1252.
Ettinger PO, Wu CF, De La Cruz C, Jr., Weisse AB, Ahmed SS, Regan TJ. Arrhythmias and the “Holiday Heart”: alcohol-associated cardiac rhythm disorders. Am Heart J 1978;95:555-562.
Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A, Mont L, Brugada J, Girona J, Domingo A, Bachinski LL, Roberts R. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997;336:905-911.
Allessie MA. Is atrial fibrillation sometimes a genetic disease? N Engl J Med 1997;336:950-951.
Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994;89:724-730.
Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 1997;336:1429-1434.
Polanczyk CA, Goldman L, Marcantonio ER, Orav EJ, Lee TH. Supraventricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay. Ann Intern Med 1998;129:279-285.
Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, Collins JJ, Cohn LH, Burstin HR. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation 1996;94:3890.
Kowey PR, Taylor JE, Rials SJ, Marinchak RA. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol 1992;69:963-965.
Daoud EG, Strickberger SA, Man KC, Goyal R, Deeb GM, Bolling SF, Pagani FD, Bitar C, Meissner MD, Morady F. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997;337:1785-1791.
American Heart Association. 1998 Heart and Stroke Statistical Update, 1997.
Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, D'Agostino RB. Stroke severity in atrial fibrillation: The Framingham Study. Stroke 1996;27:1760-1764.
Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
Gajewski J, Singer RB. Mortality in an insured population with atrial fibrillation. JAMA 1981;245:1540-1544.
Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995;98:476-484.
Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998;98:946-952.
Vulpian A. Note sur les effets de la faradisation directe des ventricules du coeur chez le chien. Arch Physiol Norm Pathol 1874;1:975-980.
Moe GK, Abildskov JA. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J 1959;58:59-70.
Lewis T. The Mechanism and Graphic Registration of the Heart Beat (3rd Ed). London: Shaw & Sons, 1925:319-374.
Moe GK, Rheinboldt WC, Abildskov JA. A computer model of atrial fibrillation. Am Heart J 1964;67:200-220.
Allessie MA, Lammers WEJEP, Bonke FIM, Hollen J. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In: Zipes DP and Jalife J, eds. Cardiac Electrophysiology and Arrhythmias. Orlando: Grune & Stratton, 1985;265-275.
Botteron GW, Smith JM. Quantitative assessment of the spatial organization of atrial fibrillation in the intact human heart. Circulation 1996;93:513-518.
Skanes AC, Mandapati R, Berenfeld O, Davidenko JM, Jalife J. Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart. Circulation 1998;1236-1248.
Jalife J, Berenfeld O, Skanes AC, Mandapati R. Mechanisms of atrial fibrillation: Mother rotors or multiple daughter wavelets, or both? J Cardiovasc Electrophysiol 1998;9:S2-S12.
Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339(10):659-666.
Saksena S, Giorgberidze I, Mehra R, Hill M, Prakash A, Krol RB, Mathew P. Electrophysiology and endocardial mapping of induced atrial fibrillation in patients with spontaneous atrial fibrillation. Am J Cardiol 1999;83:187-193.
Saksena S, Prakash A, Krol RB, Shankar A. Regional endocardial mapping of spontaneous and induced atrial fibrillation in patients with heart disease and refractory atrial fibrillation. Am J Cardiol 1999;84:880-889.
Cabo C, Pertsov AM, Baxter WT, Davidenko JM, Gray RA, Jalife J. Wave-front curvature as a cause of slow conduction and block in isolated cardiac muscle. Circ Res 1994;75:1014-1028.
Rohr S, Kucera JP, Fast VG, Kleber AG. Paradoxical improvement of impulse conduction in cardiac tissue by partial cellular uncoupling. Science 1997;275:841-844.
Gray RA, Pertsov AM, Jalife J. Spatial and temporal organization during cardiac fibrillation. Nature 1998;392:75-78.
Schuessler RB, Kawamoto T, Hand DE, Mitsuno M, Bromberg BI, Cox JL, Boineau JP. Simultaneous epicardial and endocardial activation sequence mapping in the isolated canine right atrium. Circulation 1993;88:250-263.
Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 1997;81:512-525.
Escande D, Coulombe A, Faivre JF, Deroubaix E, Coraboeuf E. Two types of transient outward currents in adult human atrial cells. Am J Physiol 1987;252:H142-H148.
Van Wagoner DR, Pond AL, McCarthy PM, Trimmer JS, Nerbonne JM. Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 1997;80:772-781.
Nattel S. Ionic determinants of atrial fibrillation and calcium channel abnormalities: cause, consequence, or innocent bystander. Circ Res 1999;85:473-476.
Hara M, Shvilkin A, Rosen MR, Danilo P Jr., Boyden PA. Steady state and nonsteady-state action potentials in fibrillating canine atrium: abnormal rate adaptation and its possible mechanisms. Cardiovasc Res 1999:42:455-469.
Yue L, Feng J, Zhiguo W, Nattel S. Adrenergic modulation of the ultra-rapid delayed rectifier K+ current (Ikund) in canine atrial myocytes. (Abstract) Circulation 1998;98:I-610.
Gros D, Jarry-Guichard T, Ten Velde I, et al. Restricted distribution of connexin40, a gap junction protein, in mammalian heart. Circ Res 1994;74:839-851.
Saffitz JE, Kanter HL, Green KG, et al. Tissue-specific determinants of anisotropic conduction velocity in canine atrial and ventricular myocardium. Circ Res 1994;74:1065-1070.
Fast VG, Kleber AG. Cardiac tissue geometry as a determinant of unidirectional conduction block: assessment of microscopic excitation spread by optical mapping in patterned cell cultures and in a computer model. Cardiovasc Res 1995;29:694-707.
Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing: Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995;91:1588-1595.
Pinto JM, Boyden PA. Electrical remodeling in ischemia and infarction. Cardiovasc Res 1999;42:284-297.
Rosenbaum MB, Blanco HH, Elizari MV, Lazzari JO, Davidenko JM. Electrotonic modulation of the T wave and cardiac memory. Am J Cardiol 1982;50(2):213-222.
Geller JC, Rosen MR. Persistent T-wave changes after alteration of the ventricular activation sequence. New insights into cellular mechanisms of cardiac memory. Circulation 1993;88:1811-1819.
Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
Gaspo R, Bosch RF, Bou-Abboud E, Nattel S. Tachycardia-induced changes in Na+ current in a chronic dog model of atrial fibrillation. Circ Res 1997:81(6):1045-1052.
Feng J, Xu D, Wang Z, Nattel S. Ultrarapid delayed rectifier current inactivation in human atrial myocytes: properties and consequences. Am J Physiol 1998;275(2):H1717-1725.
Gaspo R, Sun H, Fareh S, Yeu L, Allen BG, Hebert TE, Nattel N. Biochemical mechanisms of reductions in calcium current caused by atrial tachycardia-induced electrical remodeling. (Abstract) Circulation 1998;98:1752A.
Tieleman RG, De Langen C, Van Gelder IC, de Kam PJ, Grandjean J, Bel KJ, Wijffels MC, Allessie MA, Crijns HJ. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 1997;95:1945-1953.
Fareh H, Thibault B, Nattel S. Treatment with T-type calcium channel blocker prevents atrial fibrillation caused by tachycardia induced atrial remodeling. Circulation 1998;98:1088A.
Rockman HA. Koch WJ. Lefkowitz RJ. Cardiac function in genetically engineered mice with altered adrenergic receptor signaling. Am J of Physiol 1997;272(2):H1553-1559.
Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, Marban E, Tomaselli GF. Ionic mechanisms of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 1996;78:262-273.
Li D, Feng J, Nattel S. Remodeling of atrial cellular and ionic electrophysiology by congestive heart failure. Circulation 1998;98:1749A.
Cohn JN, Levin TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic heart failure. N Engl J Med 1984;311:819-823.
Zhang L, Wang Z, Nattel S. Chronic adrenergic stimulation induces ionic remodeling in cultured adult guinea pig ventricular myocytes. Circulation 1998;98:1755A.
Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997;96:3157-3163.
Gaspo M, Bosch MR, Talajic M, Nattel S. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation 1997;96(11):4027-4035.
Giorgberidze I, Saksena S, Krol RB, Prakash A, Munsif A, Mathew P. Catheter endocardial mapping of spontaneous termination of atrial fibrillation. (Abstract) PACE 1997;20:1065.
Courtemache M, Ramirez R, Nattel S. Ionic targets for drug therapy and AF-induced electrical remodeling: Insights from a human atrial action potential model. (Abstract) PACE 1998;21:437A.
Feng J, Wang Z, Li GR, Nattel S. Effects of class III antiarrhythmic drugs on transient outward and ultra-rapid delayed rectifier currents in human atrial myocytes. J Pharmacol Experimental Therapeutics 1997;281:384-392.
Esmon C. The protein C anticoagulant pathway. Arterioscl Thromb 1992;12:135-145.
Esmon C. Cell mediated events that control blood coagulation and vascular injury. Annu Rev Cell Biol 1993;9:1-26.
Nemerson Y. Tissue factor and hemostasis. Blood 1988;71:1-8.
Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991;66:67-79.
Carson SD, Brozna JP. The role of tissue factor in the production of thrombin. Blood Coagul Fibrinolysis 1993;4:281-292.
Pawashe A, Golino P, Ambrosio G, Migliaccio F, Ragni M, Pascucci I, Chiarello M, Garen A, Konigsberg W, Ezekowitz MD: A monoclonal antibody against rabbit tissue factor inhibits intravascular thrombosis. Circulation Res 1994;74(1):56-63.
Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: implications of disorders of hemostasis and thrombosis. Am J Pathol 1989;134:1087-1097.
Channon KM, Fulton GJ, Davies MG, Peters KG, Ezekowitz MD, Hagen PO, Annex BH. Modulation of tissue factor protein expression in experimental venous bypass grafts. Arterioscler Thromb Vasc Biol 1997;17:1313-1319.
Marmur JD, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman MB. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest 1993;91:2253-2259.
Speidel CM, Eisenberg PR, Ruf W, Edgington TS, Abendschein DR. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits. Circulation 1995;92:3323-3330.
Gilino P, Ragni M, Cirillo P, Avvidimento VE, Feliciello A, Esposito N, Scognamilio A, Trimaco B, Iaccarino G, Condorelli M, Chiariello M, Ambrosio G. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med 1996;2:35-40.
Heiss WD, Forsting M, Dienes HC. Imaging in cardiovascular disease. Curr Opin Neurol 2001;14:67-75
Lake FR, Cullen KJ, de Klerk NH, McCall MG, Rosman DL. Atrial fibrillation and mortality in an elderly population. Aust NZ J Med 1989;19:321-326.
The National Institute of Neurological Disorders and Stroke rt-PA Study Group. Tissue plasminogen activation for acute ischemic stroke. N Engl J Med 1995;333:1581-1593.
Zito M, Muscari A, Marini E, et al. Silent lacunar infarcts in elderly patients with chronic nonvalvular atrial fibrillation. Aging 1996;8:341-346.
Ezekowitz MD, James KE, Nazarian SM, Davenport J, Broderick JP, Gupta SR, Thadani V, Meyer ML, Bridgers SL. For the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. Circulation 1995;92:2178-2182.
Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998;18:583-609.
Tong DC, Albers GW. Transcranial Doppler-detected microemboli in patients with acute stroke. Stroke 1995;26:1588-1592.
Eldar M, Ohad DG, Goldberger JJ, Rotstein Z, Hsu S, Swanson DK, Greenspon AJ. Transcutaneous multielectrode basket catheter for endocardial mapping and ablation of ventricular tachycardia in the pig. Circulation 1997;96:2430-2437.
Pitschner HF, Berkovic A, Grumbrecht S, Neuzner J. Multielectrode basket catheter mapping for human atrial fibrillation. J Cardiovasc Electrophysiol 1998;9(Suppl):S48-S56.
Shpun S, Gepstein L, Hayamg G, Ben-Haim SA. Guidance of radiofrequency endocardial ablation with real-time three-dimensional magnetic navigation system. Circulation 1997;96:2016-2021.
Peters NS, Jackman WM, Schilling RJ, Beatty G, Davies DW. Human left ventricular endocardial activation mapping using a novel noncontact catheter. Circulation 1997;95:1658-1660.
Stellbrink C, Diem B, Schauert P, Ziegert K, Hanrath P. Transcoronary venous radiofrequency catheter ablation of ventricular tachycardia. J Cardiovasc Electrophysiol 1997;8:916-921.
Kuck K-H, Ernst S, Cappato R, et al. Nonfluoroscopic endocardial catheter mapping of atrial fibrillation. J Cardiovasc Electrophysiol 1998;9(Suppl):S57-S62.
Packer DP, Willis NP, Johnson SB. Guidance of linear lesion creation with a novel three dimensional intracardiac ultrasound ranging guidance system: A feasibility assessment. (Abstract) Circulation 1998;98:(Suppl I):1-643.
Wittkampf FH, Derksen R, Wever EF, Wilde AA. Loca Lisa: Electrical localization of endocardial electrodes. (Abstract) PACE 1997;20:1075.
Robb RA, Barillot C. Interactive display and analysis of 3-D medical images. IEEE Trans Med Imaging 1989;8(3):217-226.
Girouard SD, Pastore JM, Laurita KR, Gregory KW, Rosenbaum DS. Optical mapping in a new guinea pig model of ventricular tachycardia reveals mechanisms for multiple wavelengths in a single reentrant circuit. Circulation 1996;93:603-613.
Cox JL, Canavan TE, Schuessler RB, et al. The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 1991;101:406-426.
Jais P, Haissaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M, Clementy J. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997;95:572-576.
Swartz JF, Pellersels G, Silvers J, et al. A catheter-based curative approach to atrial fibrillation in humans. (Abstract) Circulation 1994;90(part 2):1-335.
Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-666.
Pappone C, Oreto G, Furlanello F, Loricchio ML, Vicedomini G, Bianchi S, Shpun S, D'Ascia C, Calabro MP, Dicandia C, Ben-Haim SA, Russo T, Chierchia S. Clinical impact of electroanatomically guided catheter compartmentation of human atria in the treatment of paroxysmal atrial fibrillation. G Ital Cardiol 1998;28:29-36.
Packer DL, Bednarek MC, Johnson SB. Chronic outcome of circumferential lesion creation in the pulmonary veins with a novel tandem balloon ablation catheter in dogs. (Abstract) Circulation 1998;98(Suppl I):I-642.
Liem LB, Mead RH, Shenasa M, Chun S, Hayase M, Kernoff R. Microwave catheter ablation using a clinical prototype system with a lateral fringe antenna design. PACE 1998;21:714-721.
Dubuc M, Talajic M, Roy D, Thibault B, Leung TK, Friedman PL. Feasibility of cardiac cryoablation using a transvenous steerable electrode catheter. J Intervent Card Electrophysiol 1998;2:285-292.
Solbiati L. New applications of ultrasonography: interventional ultrasound. Eur J Radiol 1998;27(Suppl 2):S200-S206.
Weber HP, Heinze A, Zhuang S. Laser catheter ablation of chronic persistent atrial fibrillation. (Abstract) PACE 1999;22:A26.
Haissaguerre M, Gencel L, Fischer B, Clementy J. Successful catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 1994;5:1045-1052.
Coumel P, Friocourt P, Mugica J, Attuel P, LeClercq JF. Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90/minute: Experience with 6 cases. PACE 1983;6:552-560.
Attuel P, Pellerin D, Mugica J, et al. DDD pacing: An effective treatment modality for recurrent atrial arrhythmias. PACE 1988;11:1647-1654.
Andersen HR, Nielsen JC, Thomsen PEB, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;305:1210-1216.
Connolly SJ, Kerr CR, Gent Meral; Proberts RS, Yusaf S, Gillis AM, Sami MH, Talajic M, Tang AS, Klein GJ, Lau C, Newman DM. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. CToff investigators, New Engl J Med 2000;342:1385-1391
Gillis AM, Connolly SJ, Yee R, Dubuc M, Phillipon F, Lacombe P, Kerr CR, Wyse DG for the PA3 Investigators. Atrial pacing peri-ablation for paroxysmal atrial fibrillation—Phase I. (Abstract) PACE 1998;21(II):872.
Saksena S, Prakash A, Hill M, Krol RB, Munsif AN, Mathew PP, Mehra R. Prevention of recurrent atrial fibrillation with chronic dual site right atrial pacing. J Am Coll Cardiol 1996;28:687-694.
Delfaut P, Saksena S, Prakash A, Krol RB. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single and dual site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol 1998;32:1900-1908.
Daubert C, Mabo PH, Berder V, Gras D, Leclercq C. Atrial tachyarrhythmias associated with high degree interatrial conduction block: prevention by permanent atrial resynchronisation. Eur J Cardiac Pacing Electrophysiol 1994;1:35-44.
Prakash A, Delfaut P, Krol RB, Saksena S. Regional right and left atrial activation patterns during single and dual site atrial pacing in patients with atrial fibrillation. Am J Cardiol 1998;82:1197-1204.
Murgatroyd FD, Nitzsche R, Slade AKB, et al. A new pacing algorithm for overdrive suppression of atrial fibrillation. PACE 1994;17:1966-1973.
Ricci R, Puglisi A, Azzolini P, Spampinato A, Bellocci F, Padeletti L, Capucci A, Boriani G, Marchini A, Cavaglia S, De Seta F. Consistent atrial pacing algorithm to suppress recurrent paroxysmal atrial fibrillation: A randomized prospective cross over study. (Abstract) PACE 1998;21(II):798.
Cooper RAS, Plumb VJ, Epstein AE, Kay GN, Ideker RE. Marked Reduction in internal atrial defibrillation thresholds with dual-current pathways and sequential shocks in humans. Circulation 1998;97:2527-2535.
Saksena S, Prakash A, Mongeon L, Varanasi S, Kolettis T, Mathew P, DeGroot P, Mehra R, Krol RB. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations. Am J Cardiol 1995;76:913-921.
Tse HF, Lau CP. Is there a role for cardioversion of very chronic atrial fibrillation by transvenous atrial defibrillation. (Abstract) J Am Coll Cardiol 1998;31(2):332A.
Wellens HJJ, Lau C-P, Lüderitz B, Akhtar M, Waldo AL, Camm AJ, Timmermans C, Tse H-F, Jung W, Jordaens L, Ayers G. For the METRIX Investigators. Atrioverter: An implantable device for the treatment of atrial fibrillation. Circulation 1998;98:1651-1656.
Jung W, Lüderitz B. Implantation of an arrhythmia management system for ventricular and supraventricular tachyarrhythmias. Lancet 1997;349:853-854.
Lerman B, Stein K, Markowitz S. For the Worldwide 7250 Clinical Investigators. Worldwide clinical experience with the Model 7250 Jewel AF dual chamber arrhythmia management device. (Abstract) PACE 1998;21(II):872.
Bailin SJ, Sulke N, Swerdlow C. For the Jewel AF only investigators. Clinical experience with a dual chamber implantable cardioverter defibrillator in patients with atrial fibrillation and flutter. (Abstract) PACE 1999:22:871.
Jung J, Heisel A, Fries R, Kollner V. Tolerability of internal low-energy shock strengths currently needed for endocardial atrial cardioversion. Am J Cardiol 1997;80:1489-1490.
Kleine P, Liebold A, Blommaert D. Interim results of a multicenter trial of temporary epicardial surgical wires used for the treatment of postoperative atrial fibrillation. (Abstract) PACE 1998;21(II):807.
Giorgberidze I, Saksena S, Mongeon L, Mehra R, Krol RB, Munsif AN, Mathew P. Effects of high-frequency atrial pacing in atypical atrial flutter and atrial fibrillation. J Intervent Card Electrophysiol 1997;1:111-123.
Jung W, Wolpert C, Spehl S, Tenser D, Schumacher B, Esmailzadeh B, Lüderitz B. A prospective randomized comparison of high frequency burst pacing with antitachycardia ramp pacing for termination of induced atrial tachycardias. (Abstract) J Am Coll Cardiol 1998;31(2):357A.
Prakash A, Saksena S, Mathew P, Krol R. Internal atrial defibrillation: Effect on sinus and atrioventricular nodal function and implanted cardiac pacemakers. PACE 1997;20:2434-2441.
Danias PG, Caulfield TA, Weigner MJ, Silverman DI, Manning WJ. Likelihood of atrial fibrillation to sinus rhythm. J Am Coll Cardiol 1998;31:588-592.
Dell'Orfano JT, Patel H, Wolbrette DL, Luck JC, Naccarelli GV. Acute treatment of atrial fibrillation: spontaneous conversion rates and cost of care. Am J Cardiol 1999;83:785-790.
Capucci A, Boriani G, Rubino I, Della Casa S, Sanguinetti M, Magnani B. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol 1994;43:305-313.
Boriani G, Biffi M, Capucci A, Luca Botto G, Broffoni T, Rubino I, Della Casa S, Sanguinetti M, Magnani B. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. Ann Intern Med 1997;126:621-625.
Galve E, Rius T, Ballester R, Artaza M, Arnau JM, Garcia-Dorado D, Soler-Soler J. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol 1996;27:1079-1082.
Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, VanderLugt JT, and the Ibutilide Repeat Dose Study Investigators. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 1996;94:1613-1621.
Volgman AS, Carberry PA, Stambler B, Lewis WR, Dunn GH, Perry KT, VanderLugt JT, Kowey PR. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 1998;31:1414-1419.
Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N Engl J Med 1999;341:857-865.
Kowey PR, VanderLugt JT, Luderer JR. Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter. Am J Cardiol 1996;78(Suppl 8A):46-52.
Crijns HJ, van Gelder IC, Lie KI. Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment. Am J Cardiol 1988;62:1303-1306.
Feld GK, Chen P-S, Nicod P, Fleck RP, Meyer D. Possible atrial proarrhythmic effects of class IC antiarrhythmic drugs. Am J Cardiol 1990;66:378-383.
Brignole M, Menozzi C, Gianfranchi L, et al. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacologic treatment in patients with heart failure and chronic atrial fibrillation. Circulation 1998;98:953-960.
Natale A, Zimerman L, Tomassoni G, et al. Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response. Am J Cardiol 1996;78:1431-1433.
Fitzpatrick AD, Kourouyan HD, Siu A, et al. Quality of life and outcomes after radiofrequency His bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation. Am Heart J 1996;131:499-507.
Geelen P, Goethals M, de Bruyere B, Brugada P. A prospective hemodynamic evaluation of patients with chronic atrial fibrillation undergoing radiofrequency catheter ablation of the atrioventricular junction. Am J Cardiol 1997;80:1606-1609.
Heinz G, Siostrozonek P, Kreiner G, Gossinger H. Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol 1992;69:489-492.
Gianfranchi L, Brignole M, Menozzi C, Lolli G, Bottoni N. Progression of permanent atrial fibrillation after atrioventricular junction ablation and dual-chamber pacemaker implantation in patients with paroxysmal atrial tachyarrhythmias. Am J Cardiol 1998;81:351-354.
Kay GN, Ellenbogen KA, Giudici M, Redfield MM, Jenkins LS, Mianulli M, Wilkoff B and the APT Investigators. The Ablate and Pace Trial: A prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. J Intervent Cardiac Electrophysiol 1998;2:121-135.
Lee SH, Chen SA, Tai CT, Chiang CE, Wen ZC, Cheng JJ, Ding YA, Chang MS. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol 1998;31(3):637-644.
Lown B, Amarasingham R, Neuman J. New method for terminating cardiac arrhythmias—use of synchronised capacitor discharge. JAMA 1962;182:548-555.
Lown B, Perlroth MG, Bey SK, Abe T. “Cardioversion” of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients. N Engl J Med 1963;269:325-331.
Falk RH. Current management of atrial fibrillation. Curr Opin Cardiol 1994;9:30-39.
Ewy GA. The optimal technique for electrical cardioversion of atrial fibrillation. Clin Cardiol 1994;17:79-84.
Ricard P, Levy S, Trigano J, Paganelli F, Daoud E, Man KC, Strickberger SA, Morady F. Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation. Am J Cardiol 1997;79:815-816.
Golzari H, Cebul RD, Bahler RC. Atrial fibrillation: Restoration and maintenance of sinus rhythm and indications for anticoagulation therapy. Ann Intern Med 1996;125:311-323.
Dalzell GW, Anderson J, Adgey AA. Factors determining success and energy requirements for cardioversion of atrial fibrillation. Quart J Med 1990;76:903-913.
Rights and permissions
About this article
Cite this article
Saskena, S., Domanski, M.J., Benjamin, E.J. et al. The World of Pacing and Electropysiology: Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. J Interv Card Electrophysiol 5, 345–364 (2001). https://doi.org/10.1023/A:1011489306778
Issue Date:
DOI: https://doi.org/10.1023/A:1011489306778